Immunodeficiency common variable and Progressive multifocal leukoencephalopathy

Summary:

Progressive multifocal leukoencephalopathy is found among people with Immunodeficiency common variable, especially for people who are female, 60+ old.

The study analyzes which people have Progressive multifocal leukoencephalopathy with Immunodeficiency common variable. It is created by eHealthMe based on reports of 13 people who have Immunodeficiency common variable from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Immunodeficiency common variable?

Immunodeficiency common variable is found to be associated with 86 drugs and 143 conditions by eHealthMe. Check the latest studies of Immunodeficiency common variable.

What is Progressive multifocal leukoencephalopathy?

Progressive multifocal leukoencephalopathy (rapidly progressive neuromuscular disease caused by opportunistic infection of brain cells) is found to be associated with 592 drugs and 921 conditions by eHealthMe. Check the latest studies of Progressive multifocal leukoencephalopathy.

On Aug, 03, 2026

13 people who have Immunodeficiency Common Variable and Progressive Multifocal Leukoencephalopathy are studied.

Would you have Progressive multifocal leukoencephalopathy when you have Immunodeficiency common variable?

Gender of people who have Immunodeficiency Common Variable and experienced Progressive Multifocal Leukoencephalopathy *:

female: 72.73 %
male: 27.27 %

Age of people who have Immunodeficiency Common Variable and experienced Progressive Multifocal Leukoencephalopathy *:

Common co-existing conditions for these people *:

Lower Respiratory Tract Inflammation: 1 person, 7.69%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 1 person, 7.69%
Bronchiectasis (abnormal widening of the bronchi or their branches, causing a risk of infection): 1 person, 7.69%

Common drugs taken by these people *:

Common symptoms for these people *:

Fall: 5 people, 38.46%
White Blood Cell Count Decreased: 4 people, 30.77%
Memory Loss: 4 people, 30.77%
Nausea (feeling of having an urge to vomit): 4 people, 30.77%
Fatigue (feeling of tiredness): 4 people, 30.77%
Vision Blurred: 4 people, 30.77%
Jc Virus Infection: 3 people, 23.08%
Weight Decreased: 3 people, 23.08%
Developmental Reading Disorder: 2 people, 15.38%
Diplopia (double vision): 2 people, 15.38%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Progressive multifocal leukoencephalopathy?

- Check whether Progressive multifocal leukoencephalopathy is associated with a drug or a condition

Related studies:

Treatments, associated drugs and conditions:

Immunodeficiency common variable (31,613 reports)
Progressive multifocal leukoencephalopathy (13,731 reports)

All the drugs that are associated with Progressive multifocal leukoencephalopathy:

Progressive multifocal leukoencephalopathy (592 drugs)

All the conditions that are associated with Progressive multifocal leukoencephalopathy:

Progressive multifocal leukoencephalopathy (921 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Progressive multifocal leukoencephalopathy and Immunodeficiency common variable, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.